sectionstar
(2)
Clarapath
Clarapath is a Hawthorne, New York medical robotics company that automates one of the most manual steps in cancer diagnosis: cutting and transferring paper-thin tissue sections onto slides for pathologists to read. Its flagship system, SectionStar, combines robotics, machine vision and AI to standardize tissue sectioning, cut turnaround times and ease chronic staffing shortages in histology labs. Founded in 2014 out of neuroanatomy research at Cold Spring Harbor Laboratory, the company has raised roughly $75 million and works with partners including the Mayo Clinic and Northwell Health.
Eric Feinstein
Eric Feinstein is the President and CEO of Clarapath, a Hawthorne, New York medical robotics company automating one of the last manual corners of the pathology lab: cutting and mounting tissue for diagnosis. Under his leadership Clarapath built SectionStar, an FDA-registered robotic microtomy platform, acquired the digital-pathology software firm Crosscope, forged a research collaboration with Mayo Clinic, and closed a $36M Series B in 2024. A former medical-device investor and operator with an MBA from Cornell, Feinstein frames the histology lab as a Lean Six Sigma manufacturing operation and pitches a broader vision he calls Laboratory 2.0.